Skip to main content
SpringerLink
Log in

Dolutegravir, efavirenz: maternal & paediatric effects

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Dugdale CM, et al. Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential: A Modeling Study. Annals of Internal Medicine : 2 Apr 2019. Available from: URL: http://doi.org/10.7326/M18-3358

  2. Hoffman RM, et al. Decision-Making in a Time of Uncertainty: Dolutegravir for Reproductive-Age Women. Annals of Internal Medicine : 2 Apr 2019. Available from: URL: http://doi.org/10.7326/M19-0641

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dolutegravir, efavirenz: maternal & paediatric effects. Reactions Weekly 1748, 7 (2019). https://doi.org/10.1007/s40278-019-59923-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-59923-z

Search

Navigation